About Anavex (AVXL)
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to tr... Read more
- USD9.12
- USD9.61
- USD9.07
- USD14.44
- 22.40%
- --
- 683.07k
- 961.62k
- 809M
- 4.00
- 118.50%
Stock News
yesterday
An upgrade for Apple’s stock? It’s not the endorsement you might think.
MarketWatch
yesterday
Jim Cramer explains how Microsoft, Meta and Nvidia led the Mag 7 pack in the first half of 2025
CNBC
yesterday
Bank of America Comments on Stress Test Results; Plans to Increase Quarterly Dividend 8% to $0.28 Per Share
Yahoo
yesterday
Mark Zuckerberg's costly AI talent push has not cost Meta stock yet. Here's why
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
